NUTEX Befektetesi Nyrt is a Hungary-based company engaged in the research, development, manufacturing and distribution of medicinal products. Together with its daughter companies it forms Nutex Group. The Group also provides to its consumers health conserving, health improving, dietary supplement and cosmetic products. Its brand names include Enerex and Organic Mission. NUTEX Befektetesi Nyrt operates in Hungary, Slovakia and the United Kingdom, as well as in Canada, Taiwan, Iran, the United Arab Emirates, Mexico and Hong Kong.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
11/09/26	HUF 12.00	-4.38%	53,042
10/09/26	HUF 12.55	+4.58%	413,020
09/09/26	HUF 12.00	-4.00%	920,500
08/09/26	HUF 12.50	-3.10%	59,722
07/09/26	HUF 12.90	+0.39%	220

Delayed Quote Budapest S.E.

More quotes

Market Closed - Budapest S.E. 19:19:59 11/09/2026 +04			5-day change	1st Jan Change
12.00 ^HUF	-4.38%		-6.61%	-14.29%

04-07	NUTEX Investments Public Limited Company Reports Earnings Results for the Full Year Ended December 31, 2025	CI
29/09/25	NUTEX Investments Public Limited Company Reports Earnings Results for the Half Year Ended June 30, 2025	CI

Market Cap	1.9B 6.07M 5.23M 4.96M 4.49M 8.43M 580M 8.47M 58.85M 22.63M 295M 22.81M 22.31M 933M	P/E 2024	8.58x	P/E 2025	4.12x
Enterprise Value	-3.47B -11.09M -9.56M -9.05M -8.2M -15.39M -1.06B -15.47M -107M -41.33M -539M -41.66M -40.75M -1.7B	EV / Sales 2024	-3,432x	EV / Sales 2025	-7,013x
Free-Float	78.07%	Yield 2024 *	-	Yield 2025	-

04-07	NUTEX Investments Public Limited Company Reports Earnings Results for the Full Year Ended December 31, 2025	CI
29/09/25	NUTEX Investments Public Limited Company Reports Earnings Results for the Half Year Ended June 30, 2025	CI
23/04/25	NUTEX Investments Public Limited Company Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/09/24	NUTEX Investments Public Limited Company Reports Earnings Results for the Half Year Ended June 30, 2024	CI
26/04/24	NUTEX Investments Public Limited Company Reports Earnings Results for the Full Year Ended December 31, 2023	CI
28/09/23	NUTEX Investments Public Limited Company Reports Earnings Results for the Half Year Ended June 30, 2023	CI
27/04/23	NUTEX Investments Public Limited Company Reports Earnings Results for the Full Year Ended December 31, 2022	CI
30/09/22	NUTEX Investments Public Limited Company Reports Earnings Results for the Half Year Ended June 30, 2022	CI

03-02	NUTEX Investments Public : Tájékoztatás a szavazati jogok számáról	PU
01-31	NUTEX Investments Public : Tájékoztatás a szavazati jogok számáról	PU
01-05	NUTEX Investments Public : Tájékoztatás a szavazati jogok számáról	PU
12-15	NUTEX Investments Public : Rendkívüli tájékoztatás	PU
12-06	NUTEX Investments Public : Rendkívüli tájékoztatás	PU

NUTEX Investments Public Limited Company Stock

Stocks

NUTEX

HU0000207634

Pharmaceuticals

Valuation : NUTEX Investments Public Limited Company

Chart: NUTEX Investments Public Limited Company

Latest news : NUTEX Investments Public Limited Company

Press Releases : NUTEX Investments Public Limited Company

Quotes and Performance

Price Extremes

Managers and Directors : NUTEX Investments Public Limited Company

Generic Pharmaceuticals

Financials

Company Profile

Quotes

1 day	-4.38%
1 week	-6.61%
Current month	-7.69%
1 month	-7.69%
3 months	-14.89%
6 months	-20.00%
Current year	-14.29%

1 week	11.95	12.9
1 month	11.95	13.45
Current year	11.95	17.3
1 year	11.95	17.35
3 years	10.6	27.8
5 years	7.2	27.8
10 years	7.2	117

Director	Title	Age	Since
Gábor Sándor Csereklei BRD	Director/Board Member	43	26/04/2014
Dóra Kopros BRD	Director/Board Member	41	-
Viola Ágota Vargha BRD	Director/Board Member	38	-

	2024	2025
Net sales	450K 1.44K 1.24K 1.17K 1.06K 1.99K 137K 2K 13.93K 5.36K 69.87K 5.4K 5.28K 221K	450K 1.44K 1.24K 1.17K 1.06K 1.99K 137K 2K 13.93K 5.36K 69.87K 5.4K 5.28K 221K
Net income	423M 1.35M 1.17M 1.1M 1M 1.88M 129M 1.89M 13.11M 5.04M 65.74M 5.08M 4.97M 208M	494M 1.58M 1.36M 1.29M 1.17M 2.19M 151M 2.2M 15.3M 5.88M 76.73M 5.93M 5.8M 242M
Net Debt	-4.77B -15.25M -13.14M -12.44M -11.28M -21.15M -1.46B -21.26M -148M -56.82M -741M -57.27M -56.01M -2.34B	-5.37B -17.17M -14.79M -14.01M -12.69M -23.82M -1.64B -23.94M -166M -63.97M -834M -64.47M -63.06M -2.64B

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NUTEX INVESTMENTS PUBLIC LIMITED COMPANY	-4.38%	-6.61%	-25.93%	+9.09%	6.07M
SUN PHARMACEUTICAL INDUSTRIES LTD.	-1.13%	-3.11%	+13.82%	+60.66%	46.21B
OTSUKA HOLDINGS CO., LTD.	-1.13%	-5.78%	+33.26%	+108.13%	38.78B
ZYDUS LIFESCIENCES LIMITED	+0.12%	-0.08%	+7.12%	+78.27%	11.68B
CIPLA LIMITED	-0.53%	-1.37%	-13.25%	+10.18%	11.55B
KRKA, D. D.	-0.38%	-2.26%	+18.18%	+139.63%	9.14B
GEDEON RICHTER	+0.32%	-2.26%	+23.08%	+34.73%	7.3B
GLENMARK PHARMACEUTICALS LIMITED	+0.17%	-0.74%	+13.44%	+197.13%	7.15B
ONO PHARMACEUTICAL CO., LTD.	-1.00%	-5.25%	+34.34%	-19.63%	7.1B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-3.13%	-4.30%	-44.88%	+11.66%	4.97B
Average	-1.11%	-2.99%	+5.92%	+62.99%	14.39B
Weighted average by Cap.	-0.86%	-3.27%	+16.05%	+75.66%